Editorial: 2022 in review: allergen immunotherapydoi:10.3389/falgy.2024.1431413Cox, LindaKulis, MikeFrontiers in Allergy
In this review, we focus on the connection between epigenetic regulation (DNA and histone modifications) and the tumor microenvironment in CRC patients and emphasize the application of epigenetic drug-sensitizing immunotherapy. We also discuss some epigenetic genes as immunotherapeutic markers to guide bet...
H. The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature. Clin. Cancer Res. 18, 3022–3029 (2012). Article CAS PubMed Google Scholar Yuan, X., Cheng, G. & Malek, T. R. The importance of regulatory T-cell heterogeneity in ...
nature nature reviews immunology review articles article Review Article Published: 25 January 2024 New immune cell engagers for cancer immunotherapyAurore Fenis, Olivier Demaria, Laurent Gauthier, Eric Vivier & Emilie Narni-Mancinelli Nature Reviews Immunology volume 24, pages 471–486 (2024)Cite this ...
This review introduces all aspects of immunotherapy in detail, and analyzes the literature related to tumor immunity to reveals the mysterious veil of immunotherapy. 2. Cellular immunotherapy for tumors Immune cells can identify and kill tumors. By stimulating immune cells and using the body's own ...
1 ImmunotherapyGBR83%similarity2 Cancer Immunology, ImmunotherapyDEU82%similarity3 Nature Reviews Clinical OncologyGBR79%similarity4 Journal for ImmunoTherapy of CancerGBR79%similarity5 Seminars in OncologyUSA77%similarity6 Expert Review of Anticancer TherapyGBR76%similarity7 Cancer Treatment ReviewsGBR76%simil...
In this review, we will summarize which advances in immunotherapy may translate into improved PDAC treatment options. In addition, we will discuss which combinatorial approaches are likely to maximize the potential of immunotherapy and, thus, may serve as light at the end of the tunnel for PDAC ...
2022,Nano Today Review article Extracellular vesicles as antigen carriers for novel vaccination avenues 2.1Cancer immunotherapy Cancerimmunotherapyis therapy applied to treat tumors using the components ofimmune systemincluding antibodies, cells, and proteins in addition recently EVs are promising candidates an...
Review Open access Published: 31 March 2022 CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy Kevin Pan, Hizra Farrukh, Veera Chandra Sekhar Reddy Chittepu, Huihong Xu, Chong-xian Pan & Zheng Zhu Journal of Experimental & Clinical Cancer Research ...
(MDSCs), are involved in TME modulation to cause immunotherapy resistance. This review highlights the role of stromal cells in modulating the breast tumor microenvironment, including the involvement of CAF-TAM interaction, alteration of tumor metabolism leading to immunotherapy failure, and other latest...